NCT01169337
Clinical Trial Information
Trial Number: NCT01169337 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Myeloma - Myeloma
Trial Title:
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Study ID:
E3A06
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01169337-D5 | There are five submissions for PMID 31652094. This dataset, NCT01169337-D5, contains data on basis of progression. Dataset NCT01169337-D1 contains baseline, treatment, and efficacy data. Dataset NCT01169337-D2 contains treatment dosage. Dataset NCT01169337-D3 contains post-baseline toxicities. Dataset NCT01169337-D4 contains patient-reported outcome quality of life data. |
| NCT01169337-D4 | There are five submissions for PMID 31652094. This dataset, NCT01169337-D4, contains patient-reported outcome quality of life data. Dataset NCT01169337-D1 contains baseline, treatment, and efficacy data. Dataset NCT01169337-D2 contains treatment dosage. Dataset NCT01169337-D3 contains post-baseline toxicities. Dataset NCT01169337-D5 contains data on basis of progression. |
| NCT01169337-D3 | There are five submissions for PMID 31652094. This dataset, NCT01169337-D3 contains post-baseline toxicities. Dataset NCT01169337-D1 contains baseline, treatment, and efficacy data. Dataset NCT01169337-D2 contains treatment dosage. Dataset NCT01169337-D4 contains patient-reported outcome quality of life data. Dataset NCT01169337-D5 contains data on basis of progression. |
| NCT01169337-D2 | There are five submissions for PMID 31652094. This dataset, NCT01169337-D2, contains treatment dosage. Dataset NCT01169337-D1 contains baseline, treatment, and efficacy data. Dataset NCT01169337-D3 contains post-baseline toxicities. Dataset NCT01169337-D4 contains patient-reported outcome quality of life data. Dataset NCT01169337-D5 contains data on basis of progression. |
| NCT01169337-D1 | There are five submissions for PMID 31652094. This dataset, NCT01169337-D1, contains baseline, treatment, and efficacy data. Dataset NCT01169337-D2 contains treatment dosage. Dataset NCT01169337-D3 contains post-baseline toxicities. Dataset NCT01169337-D4 contains patient-reported outcome quality of life data. Dataset NCT01169337-D5 contains data on basis of progression. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®